Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2021 | Impacts of COVID-19 on lung cancer diagnosis in the UK

Riyaz Shah, FRCP, PhD, Maidstone and Tunbridge Wells NHS Trust, Kent, UK, shares his highlights from BTOG 2021, in particular talking on data from studies investigating the diagnostic pathway for lung cancer during the COVID-19 pandemic, including the impacts on time to diagnosis and staging. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.


Riyaz Shah, FRCP, PhD, discloses links to Boehringer Ingelheim, AstraZeneca, Roche, BMS, MSD, Pfizer, Lilly, Novartis, Takeda and Bayer.